Key result
High-dose furosemide is linked to clinical improvement in ~100% of refractory heart failure patients.
Why the study?
High dose furosemide is rarely used in cardiac failure despite lower expected drug accumulation than in renal failure. Furthermore, the response to combined thiazide diuretics and lower-dose furosemide in severe cardiac failure is often unpredictable, ineffective, and sometimes hazardous.
Does high dose furosemide improve clinical status in patients with severe cardiac failure refractory to conventional therapy?
Observational (n=24)
Does high dose furosemide improve clinical status in patients with severe cardiac failure refractory to conventional therapy?
High dose furosemide (≥0.5 g/day) appears to be an effective and relatively safe strategy for patients with severe cardiac failure refractory to conventional therapy.
Answers are grounded in this paper and cite their sources.
High-dose furosemide may be explored in refractory heart failure; Level 5 evidence leaves open its comparative safety and efficacy.
High dose furosemide is commonly used in renal failure to induce diuresis but rarely employed in cardiac failure. As furosemide elimination depends largely on renal excretion, drug accumulation with attendant side-effects would be expected to occur more commonly with renal failure than with cardiac failure. Response to a combination of thiazide diuretics and lower doses of furosemide is often unpredictable, ineffective and sometimes hazardous. High dose furosemide (greater than or equal to 0.5 g day-1) was administered for at least four weeks in 24 patients with severe cardiac failure refractory to a lower dose and to other conventional therapy. Mean maintenance dose of furosemide was 0.7 g day-1 and the maximum dose of furosemide averaged 1.3 g day-1. A peak dose of 8 g day-1 was used successfully in one patient. Improvement was observed in all patients when dosage was increased to and above 0.5 g day-1. There were no major side-effects although new-onset gout (4) and tinnitus (1) were reported; hypokalaemia was readily controlled with spironolactone or potassium supplements. Average duration of therapy was 12 months with a maximum of 33 months. High dose furosemide is logical and effective therapy (with other measures) for severe cardiac failure and relatively safe when administered cautiously. The maximum safe dose is probably no less than that used in renal failure.
No takes yet. Share an insight, caveat, or question.
Kuchar et al. (1985) conducted an observational in Severe cardiac failure (n=24). High dose furosemide was evaluated on Clinical improvement. High dose furosemide led to clinical improvement in 100% of patients (24/24) with severe, refractory cardiac failure, with no major side effects reported over an average of 12 months.
Synapse has enriched 10 related papers. Consider them for comparative context: